These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

809 related articles for article (PubMed ID: 12782716)

  • 21. Expression of rat I-TAC/CXCL11/SCYA11 during central nervous system inflammation: comparison with other CXCR3 ligands.
    McColl SR; Mahalingam S; Staykova M; Tylaska LA; Fisher KE; Strick CA; Gladue RP; Neote KS; Willenborg DO
    Lab Invest; 2004 Nov; 84(11):1418-29. PubMed ID: 15322564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells.
    Marx N; Mach F; Sauty A; Leung JH; Sarafi MN; Ransohoff RM; Libby P; Plutzky J; Luster AD
    J Immunol; 2000 Jun; 164(12):6503-8. PubMed ID: 10843708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils.
    Gasperini S; Marchi M; Calzetti F; Laudanna C; Vicentini L; Olsen H; Murphy M; Liao F; Farber J; Cassatella MA
    J Immunol; 1999 Apr; 162(8):4928-37. PubMed ID: 10202039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties.
    Proost P; Schutyser E; Menten P; Struyf S; Wuyts A; Opdenakker G; Detheux M; Parmentier M; Durinx C; Lambeir AM; Neyts J; Liekens S; Maudgal PC; Billiau A; Van Damme J
    Blood; 2001 Dec; 98(13):3554-61. PubMed ID: 11739156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CXCL9 and 11 in patients with pulmonary sarcoidosis: a role of alveolar macrophages.
    Nishioka Y; Manabe K; Kishi J; Wang W; Inayama M; Azuma M; Sone S
    Clin Exp Immunol; 2007 Aug; 149(2):317-26. PubMed ID: 17550373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome.
    Belperio JA; Keane MP; Burdick MD; Lynch JP; Xue YY; Li K; Ross DJ; Strieter RM
    J Immunol; 2002 Jul; 169(2):1037-49. PubMed ID: 12097412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-function relationship between the human chemokine receptor CXCR3 and its ligands.
    Clark-Lewis I; Mattioli I; Gong JH; Loetscher P
    J Biol Chem; 2003 Jan; 278(1):289-95. PubMed ID: 12417585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. I-TAC/CXCL11 is a natural antagonist for CCR5.
    Petkovic V; Moghini C; Paoletti S; Uguccioni M; Gerber B
    J Leukoc Biol; 2004 Sep; 76(3):701-8. PubMed ID: 15178708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.
    Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S
    Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of overexpression of CXCL10 (cytokine-responsive gene-2) on MA-10 mouse Leydig tumor cell steroidogenesis and proliferation.
    Nagpal ML; Chen Y; Lin T
    J Endocrinol; 2004 Dec; 183(3):585-94. PubMed ID: 15590984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism.
    Iijima W; Ohtani H; Nakayama T; Sugawara Y; Sato E; Nagura H; Yoshie O; Sasano T
    Am J Pathol; 2003 Jul; 163(1):261-8. PubMed ID: 12819030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies.
    De Paepe B; De Keyzer K; Martin JJ; De Bleecker JL
    Acta Neuropathol; 2005 Jun; 109(6):576-82. PubMed ID: 15937690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells.
    Sauty A; Dziejman M; Taha RA; Iarossi AS; Neote K; Garcia-Zepeda EA; Hamid Q; Luster AD
    J Immunol; 1999 Mar; 162(6):3549-58. PubMed ID: 10092813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection.
    Zhao DX; Hu Y; Miller GG; Luster AD; Mitchell RN; Libby P
    J Immunol; 2002 Aug; 169(3):1556-60. PubMed ID: 12133984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated serum levels of the CXCR3 chemokine ITAC are associated with the development of transplant coronary artery disease.
    Kao J; Kobashigawa J; Fishbein MC; MacLellan WR; Burdick MD; Belperio JA; Strieter RM
    Circulation; 2003 Apr; 107(15):1958-61. PubMed ID: 12695288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids.
    Proost P; Verpoest S; Van de Borne K; Schutyser E; Struyf S; Put W; Ronsse I; Grillet B; Opdenakker G; Van Damme J
    J Leukoc Biol; 2004 May; 75(5):777-84. PubMed ID: 14996826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells.
    Dwinell MB; Lügering N; Eckmann L; Kagnoff MF
    Gastroenterology; 2001 Jan; 120(1):49-59. PubMed ID: 11208713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation.
    Flier J; Boorsma DM; van Beek PJ; Nieboer C; Stoof TJ; Willemze R; Tensen CP
    J Pathol; 2001 Aug; 194(4):398-405. PubMed ID: 11523046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lysophosphatidylcholine posttranscriptionally inhibits interferon-gamma-induced IP-10, Mig and I-Tac expression in endothelial cells.
    Sheikh AM; Ochi H; Manabe A; Masuda J
    Cardiovasc Res; 2005 Jan; 65(1):263-71. PubMed ID: 15621055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spatial and temporal expression of ligands for CXCR3 and CXCR4 in human endometrium.
    Kitaya K; Nakayama T; Daikoku N; Fushiki S; Honjo H
    J Clin Endocrinol Metab; 2004 May; 89(5):2470-6. PubMed ID: 15126579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.